Cas no 1028252-11-0 (5-Chloro-2-methylbenzamide)
5-Chloro-2-methylbenzamide Chemical and Physical Properties
Names and Identifiers
-
- 5-chloro-2-MethylbenzaMide
- NE54461
- Y5855
- 5-Chloro-2-methylbenzamide
-
- MDL: MFCD11044835
- Inchi: 1S/C8H8ClNO/c1-5-2-3-6(9)4-7(5)8(10)11/h2-4H,1H3,(H2,10,11)
- InChI Key: FSBZFVCIKUIIMT-UHFFFAOYSA-N
- SMILES: ClC1C=CC(C)=C(C(N)=O)C=1
Computed Properties
- Exact Mass: 169.0294416g/mol
- Monoisotopic Mass: 169.0294416g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 160
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 43.1
- XLogP3: 1.8
Experimental Properties
- Density: 1.243±0.06 g/cm3 (20 oC 760 Torr),
- Boiling Point: 250.9±33.0 oC (760 Torr),
- Flash Point: 105.5±25.4 oC,
- Solubility: Very slightly soluble (0.56 g/l) (25 o C),
5-Chloro-2-methylbenzamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A015001922-250mg |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 97% | 250mg |
$494.40 | 2023-09-04 | |
| Alichem | A015001922-500mg |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 97% | 500mg |
$823.15 | 2023-09-04 | |
| Alichem | A015001922-1g |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 97% | 1g |
$1460.20 | 2023-09-04 | |
| TRC | C370358-25mg |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 25mg |
$ 70.00 | 2022-04-01 | ||
| TRC | C370358-50mg |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 50mg |
$ 95.00 | 2022-04-01 | ||
| TRC | C370358-250mg |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 250mg |
$ 365.00 | 2022-04-01 | ||
| CHENG DOU FEI BO YI YAO Technology Co., Ltd. | XW0093-5g |
5-chloro-2-methylbenzamide |
1028252-11-0 | 95% | 5g |
$945 | 2023-09-07 | |
| Ambeed | A266459-1g |
5-Chloro-2-methylbenzamide |
1028252-11-0 | 97% | 1g |
$518.0 | 2024-04-26 | |
| A2B Chem LLC | AV52526-250mg |
5-chloro-2-methylbenzamide |
1028252-11-0 | 95% | 250mg |
$200.00 | 2024-04-20 | |
| A2B Chem LLC | AV52526-1g |
5-chloro-2-methylbenzamide |
1028252-11-0 | 95% | 1g |
$454.00 | 2024-04-20 |
5-Chloro-2-methylbenzamide Related Literature
-
Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
-
3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
-
Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
-
Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
Additional information on 5-Chloro-2-methylbenzamide
Introduction to 5-Chloro-2-methylbenzamide (CAS No. 1028252-11-0)
5-Chloro-2-methylbenzamide, identified by the Chemical Abstracts Service Number (CAS No.) 1028252-11-0, is a significant compound in the realm of pharmaceutical and biochemical research. This molecule, featuring a chlorinated aromatic ring and an amide functional group, has garnered attention due to its structural versatility and potential applications in medicinal chemistry. The presence of both electron-withdrawing and electron-donating substituents in its benzene core makes it a valuable scaffold for designing novel bioactive molecules.
The chemical structure of 5-Chloro-2-methylbenzamide consists of a benzene ring substituted with a chlorine atom at the 5-position and a methyl group at the 2-position, connected to an amide moiety. This specific arrangement imparts unique electronic and steric properties, enabling interactions with biological targets in diverse ways. The chlorine atom enhances electrophilicity, making the molecule susceptible to nucleophilic substitution reactions, while the methyl group influences the overall shape and polarity of the molecule, affecting its binding affinity to proteins.
In recent years, 5-Chloro-2-methylbenzamide has been explored as a key intermediate in the synthesis of various pharmacologically active compounds. Its role in developing small-molecule inhibitors for therapeutic applications has been particularly noteworthy. For instance, researchers have leveraged its scaffold to create molecules with potential anti-inflammatory, antimicrobial, and anticancer properties. The amide group serves as a hinge region, allowing for modifications that can fine-tune the pharmacokinetic and pharmacodynamic profiles of derived compounds.
One of the most compelling aspects of 5-Chloro-2-methylbenzamide is its utility in fragment-based drug design. By integrating this compound into virtual screening campaigns, scientists can identify hits that bind to target proteins with high affinity. Subsequent modifications to its structure can lead to the development of lead compounds with improved efficacy and reduced toxicity. This approach has been particularly successful in targeting challenging biological pathways where traditional drug discovery methods have struggled.
Recent advancements in computational chemistry have further enhanced the utility of 5-Chloro-2-methylbenzamide as a building block. Machine learning models trained on large datasets of bioactive molecules have demonstrated the ability to predict how structural modifications will affect biological activity. These models can guide synthetic chemists in designing derivatives of 5-Chloro-2-methylbenzamide that are more likely to exhibit desired properties, thereby accelerating the drug discovery process.
The synthesis of 5-Chloro-2-methylbenzamide itself presents an interesting challenge due to its functionalized aromatic core. Traditional methods involve chlorination and methylation reactions followed by amidation, but newer techniques such as transition-metal-catalyzed cross-coupling reactions offer more efficient pathways. These methods not only improve yield but also reduce waste, aligning with green chemistry principles. The development of such sustainable synthetic routes is crucial for large-scale production and commercialization.
In academic research, 5-Chloro-2-methylbenzamide has been used as a model compound to study enzyme mechanisms and substrate recognition. Its interaction with various enzymes has provided insights into how small molecules can modulate biological processes at the molecular level. For example, studies have shown that derivatives of this compound can inhibit proteases involved in inflammatory responses by binding to their active sites and blocking substrate access.
The pharmaceutical industry has also shown interest in 5-Chloro-2-methylbenzamide due to its potential as a prodrug or co-administered therapeutic agent. Prodrugs derived from this scaffold can improve solubility or bioavailability when administered orally or parenterally. Additionally, co-administration with other drugs may allow for synergistic effects by targeting multiple pathways simultaneously—a strategy increasingly employed in combination therapies for complex diseases.
Looking ahead, the future prospects for 5-Chloro-2-methylbenzamide appear promising as new methodologies emerge in synthetic chemistry and drug discovery. Advances in automation and high-throughput screening will enable rapid testing of numerous derivatives, while innovations in biocatalysis may offer greener alternatives for functionalization reactions. As our understanding of disease mechanisms deepens, compounds like 5-Chloro-2-methylbenzamide will continue to play a pivotal role in developing next-generation therapeutics.
1028252-11-0 (5-Chloro-2-methylbenzamide) Related Products
- 147699-62-5(4,5-Dichlorophthalamide)
- 2670-38-4(3,4-Dichlorobenzamide)
- 101080-58-4(2-Chloro-6-methylbenzamide)
- 619-56-7(4-Chlorobenzamide)
- 618-48-4(3-Chlorobenzamide)
- 175278-27-0(2,4-Dichloro-6-methylbenzamide)
- 5980-23-4(3,5-Dichlorobenzamide)
- 1219794-65-6(4-Chlorobenzamide-2,3,5,6-d4)
- 96385-49-8(4-Chlorophthalamide)
- 75319-02-7(4-Chloro-2-methylbenzhydrazide)